Covidien (NYSE:COV) today announced that its Mallinckrodt Inc. subsidiary is voluntarily recalling one lot of Mallinckrodt Sodium Chromate Cr-51 Injection, lot #370-9004 as a result of routine post-market testing in which the product was found to be subpotent.
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.
Covidien Initiates Nationwide Voluntary Recall of Sodium Chromate Cr-51 Injection, Lot #370-9004
- Login or register to post comments
- Feed: Food and Drug Administration--Recalls
- Original article